These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34643101)

  • 1. Cross-validating the Dot Counting Test Among an Adult ADHD Clinical Sample and Analyzing the Effect of ADHD Subtype and Comorbid Psychopathology.
    Abramson DA; White DJ; Rhoads T; Carter DA; Hansen ND; Resch ZJ; Jennette KJ; Ovsiew GP; Soble JR
    Assessment; 2023 Mar; 30(2):264-273. PubMed ID: 34643101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Every second counts: A comparison of four dot counting test scoring procedures for detecting invalid neuropsychological test performance.
    Rhoads T; Resch ZJ; Ovsiew GP; White DJ; Abramson DA; Soble JR
    Psychol Assess; 2021 Feb; 33(2):133-141. PubMed ID: 33119378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing performance validity during attention-deficit/hyperactivity disorder evaluations: Cross-validation of non-memory embedded validity indicators.
    Ausloos-Lozano JE; Bing-Canar H; Khan H; Singh PG; Wisinger AM; Rauch AA; Ogram Buckley CM; Petry LG; Jennette KJ; Soble JR; Resch ZJ
    Dev Neuropsychol; 2022 Aug; 47(5):247-257. PubMed ID: 35787068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of processing speed and memory performance on classification accuracy of the dot counting test in a mixed neuropsychiatric sample.
    Phillips MS; Wisinger AM; Cerny BM; Khan H; Chang F; Tse KYP; Ovsiew GP; Resch ZJ; Shapiro G; Soble JR; Jennette KJ
    J Clin Exp Neuropsychol; 2024 Jun; ():1-13. PubMed ID: 38847827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of alternative dot counting test E-score cutoffs based on degree of cognitive impairment in veteran and civilian clinical samples.
    Hansen ND; Rhoads T; Jennette KJ; Reynolds TP; Ovsiew GP; Resch ZJ; Critchfield EA; Marceaux JC; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2023 Feb; 37(2):402-415. PubMed ID: 35343379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Divergent Roles of Symptom and Performance Validity in the Assessment of ADHD.
    White DJ; Ovsiew GP; Rhoads T; Resch ZJ; Lee M; Oh AJ; Soble JR
    J Atten Disord; 2022 Jan; 26(1):101-108. PubMed ID: 33084457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining Conners Continuous Performance Test-3 (CPT-3) Embedded Performance Validity Indicators in an Adult Clinical Sample Referred for ADHD Evaluation.
    Scimeca LM; Holbrook L; Rhoads T; Cerny BM; Jennette KJ; Resch ZJ; Obolsky MA; Ovsiew GP; Soble JR
    Dev Neuropsychol; 2021 Aug; 46(5):347-359. PubMed ID: 34256665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-validating the Clinical Assessment of Attention Deficit-Adult symptom validity scales for assessment of attention deficit/hyperactivity disorder in adults.
    Finley JA; Cerny BM; Brooks JM; Obolsky MA; Haneda A; Ovsiew GP; Ulrich DM; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):111-123. PubMed ID: 37994688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating Performance on the Connors Continuous Performance Test (CPT-3) as a Function of Comorbid Internalizing Psychopathology.
    Brooks JM; Guilfoyle J; Alfonso D; Oh A; Nili AN; Frick LA; Resch ZJ; Soble JR; Ulrich DM
    J Atten Disord; 2024 Apr; 28(6):1024-1031. PubMed ID: 38214177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further Validation of the Conner's Adult Attention Deficit/Hyperactivity Rating Scale Infrequency Index (CII) for Detection of Non-Credible Report of Attention Deficit/Hyperactivity Disorder Symptoms.
    Cook CM; Bolinger E; Suhr J
    Arch Clin Neuropsychol; 2016 Jun; 31(4):358-64. PubMed ID: 27193367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of embedded validity indicators from the Stroop Color and Word Test among adults referred for clinical evaluation of suspected or confirmed attention-deficit/hyperactivity disorder.
    Khan H; Rauch AA; Obolsky MA; Skymba H; Barwegen KC; Wisinger AM; Ovsiew GP; Jennette KJ; Soble JR; Resch ZJ
    Psychol Assess; 2022 Jul; 34(7):697-703. PubMed ID: 35357873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) and Clinical Assessment of Attention Deficit-Adult (CAT-A) over-reporting validity scales for detecting invalid ADHD symptom reporting.
    Leib SI; Schieszler-Ockrassa C; White DJ; Gallagher VT; Carter DA; Basurto KS; Ovsiew GP; Resch ZJ; Jennette KJ; Soble JR
    Appl Neuropsychol Adult; 2022; 29(6):1522-1529. PubMed ID: 33719792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erroneous conclusions: The impact of failing to identify invalid symptom presentation when conducting adult attention-deficit/hyperactivity disorder (ADHD) research.
    Hoelzle JB; Ritchie KA; Marshall PS; Vogt EM; Marra DE
    Psychol Assess; 2019 Sep; 31(9):1174-1179. PubMed ID: 31343208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent, Discriminant, and Concurrent Validity of Nonmemory-Based Performance Validity Tests.
    Webber TA; Critchfield EA; Soble JR
    Assessment; 2020 Oct; 27(7):1399-1415. PubMed ID: 30293445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dot Counting Test adds up: Validation and response pattern analysis in a mixed clinical veteran sample.
    Soble JR; Santos OA; Bain KM; Kirton JW; Bailey KC; Critchfield EA; O'Rourke JJF; Highsmith JM; González DA
    J Clin Exp Neuropsychol; 2018 May; 40(4):317-325. PubMed ID: 28656790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of assessing for validity of symptom report and performance in attention deficit/hyperactivity disorder (ADHD): Introduction to the special section on noncredible presentation in ADHD.
    Suhr JA; Berry DTR
    Psychol Assess; 2017 Dec; 29(12):1427-1428. PubMed ID: 29227123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive performance of 5- and 6-year-old children who met criteria for attention deficit/hyperactivity disorder at 18 months follow-up: results from a prospective population study.
    Kalff AC; Hendriksen JG; Kroes M; Vles JS; Steyaert J; Feron FJ; van Zeben TM; Jolles J
    J Abnorm Child Psychol; 2002 Dec; 30(6):589-98. PubMed ID: 12481973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.